Source comparison
Best AOD-9604 Dosage for Cartilage Repair: Protocol Comparison
Monotherapy (no adjuncts) 400–500 mcg 5 days/week 16–24 weeks Type II collagen synthesis peaks at week 12–16; cartilage thickness increase visible on MRI by week 20 Best for isolated cartilage defects without significant inflammation or subchondral bone involv
This comparison does not assign a generated winner or score.
- Monotherapy (no adjuncts)
- 400–500 mcg
- 5 days/week
- 16–24 weeks
- Type II collagen synthesis peaks at week 12–16; cartilage thickness increase visible on MRI by week 20
- Best for isolated cartilage defects without significant inflammation or subchondral bone involvement
- Combined with PRP or BMAC
- 250–350 mcg
- 12–16 weeks
- Earlier collagen deposition (week 8–10); faster symptom resolution due to growth factor synergy
- Reduces peptide dose requirement; PRP handles angiogenesis while AOD-9604 drives chondrocyte proliferation
- Weight-bearing joint repair
- 5–6 days/week
- 20–24 weeks
- Slower initial response; mechanical load delays early tissue maturation but improves long-term matrix durability
- Requires longer duration; mechanotransduction enhances remodelling but extends timeline
- Non-weight-bearing joint
- 4–5 days/week
- Faster early response; less mechanical interference allows uninterrupted proliferation phase
- Can use lower dose and shorter duration due to reduced biomechanical stress
- Maintenance after initial repair
- 200–300 mcg
- 3 days/week
- Indefinite or until imaging confirms stability
- Prevents re-degradation; maintains chondrocyte metabolic activity without triggering hyperplasia
- Lower frequency prevents receptor downregulation while sustaining repair gains